SPRY (ars-pharma.com) Bozor qiymatining balans qiymatiga nisbati
ARS Pharmaceuticals (SPRY) o'zining ignasiz spreyiga muqobil variantlar yo'qligi sababli ulkan narx belgilash imkoniyatiga ega, buni 30.47 ko'rsatkichi tasdiqlaydi. Shifokorlar va bemorlarning yuqori darajadagi ishonchi anafilaktik shok bilan kurashishga qaratilgan davolash usullarining ishonchliligiga asoslangan. Tarixiy narxlar dinamikasi ushbu inqilobiy yechimning muvaffaqiyatini namoyish etadi, u inyeksiyalarni hamma uchun ochiq bo'lgan og'riqsiz burun formatiga almashtirdi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_SPRY_-_ARS-Pharmaceuticals_-_Market-Capitalization-to-Net-Assets "SPRY ARS Corp Bozor kapitallashuvining balans qiymatiga nisbati (28.04.2023 - 27.10.2026) | 👁️GURU.Markets👁️")
ARS Pharmaceuticals Inc (SPRY) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:ARS Pharmaceuticals - SPRY
ARS Pharmaceuticals (SPRY) kompaniyasining inqilobiy burun spreyining shiddatli tijorat o'sishi baholash e'tiborini joriy aktivlardan kelajakdagi pul oqimlariga ko'chirmoqda. ARS Pharmaceuticals (SPRY) uchun P/BV grafigini tahlil qilib, investor bozor qiymatining sof kapitalga nisbatini ko'rishi mumkin, bu esa innovatsiya premiumini aniqlash va aktivning kitob qiymatiga nisbatan haddan tashqari sotib olingan holatini baholash imkonini beradi.
Asosiy raqobatchilar
Kapitallashuvning sof aktivlarga nisbati HLN|KVUE (kenvue.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|Theravance Biopharma, Inc. (TBPH) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AQST (Aquestive Therapeutics Inc)|SCPH: Bozor qiymatining balans qiymatiga nisbati|TECX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tonix Pharmaceuticals TNXP|SXTC - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EXOZ (Invizyne Technologies, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ipatherapeutics.com (HYFT)|Bozor kapitallashuvining balans qiymatiga nisbati ABVC (ABVC BioPharma, Inc.)|Cumberland Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Quantum BioPharma Limited (QNTM)|FGEN: Balans qiymatiga nisbatan bozor qiymati|Telomir Pharmaceuticals - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Rani Therapeutics Holdings, Inc.|SNYR - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati RLYB|LEXX - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Pulmatrix Corporation (PULM)|Bozor kapitallashuvining balans qiymatiga nisbati Pheton Holdings|Balans qiymatiga nisbatan bozor qiymati Aptorum Group Ltd APM|Lyra Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|IBO: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati tnfpharma.com TNFA|YCBD (cbdMD) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati PRFX|Kapitallashuvning sof aktivlarga nisbati Auris Medical|Bozor kapitallashuvining balans qiymatiga nisbati LIPO|Bozor kapitallashuvining balans qiymatiga nisbati OptiNose Inc (OPTN)|Pieris - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Procaps Group Corp PROC|PTPI (Petros Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|qlsyy.net (QLI) - Bozor qiymatining balans qiymatiga koeffitsiyenti|SLRN: Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TFF Pharmaceuticals Inc.